Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chapman

Showing results (861-870 of 891) with videos related to

Pageof 90
Sort By:
Blood|March 11, 2004
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groupsHanneke C Kluin-Nelemans, Georgina Buck, Saskia le Cessie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2001
Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinaseA Mudher, S Chapman, J Richardson, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Genome Research|August 2, 2015
Comparison against 186 canid whole-genome sequences reveals survival strategies of an ancient clonally transmissible canine tumorBrennan Decker, Brian W Davis, Maud Rimbault, et al.
Trials|January 28, 2023
Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocolLara S Chapman, Anthony C Redmond, Caroline A Flurey, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Nature Communications|December 20, 2025
Reconstructing the three-dimensional architecture of extrachromosomal DNA with ec3DBiswanath Chowdhury, Kaiyuan Zhu, Chaohui Li, et al.
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism|February 28, 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continentsLara S Chapman, Caroline A Flurey, Pamela Richards, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastomaMeher Beigi Masihi, Kendall R Chambers, Richard A Friedman, et al.
Pageof 90

Showing results (861-870 of 891) with videos related to

Sort By:
Pageof 90
Blood|March 11, 2004
Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groupsHanneke C Kluin-Nelemans, Georgina Buck, Saskia le Cessie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2001
Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinaseA Mudher, S Chapman, J Richardson, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Genome Research|August 2, 2015
Comparison against 186 canid whole-genome sequences reveals survival strategies of an ancient clonally transmissible canine tumorBrennan Decker, Brian W Davis, Maud Rimbault, et al.
Trials|January 28, 2023
Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocolLara S Chapman, Anthony C Redmond, Caroline A Flurey, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Nature Communications|December 20, 2025
Reconstructing the three-dimensional architecture of extrachromosomal DNA with ec3DBiswanath Chowdhury, Kaiyuan Zhu, Chaohui Li, et al.
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
Seminars in Arthritis and Rheumatism|February 28, 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continentsLara S Chapman, Caroline A Flurey, Pamela Richards, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastomaMeher Beigi Masihi, Kendall R Chambers, Richard A Friedman, et al.
Pageof 90